Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    December 23, 2014December 23, 2014

    IBM Developing Intelligent Skin Lesion Analysis Diagnostic Technology

    News
    Multinational technology and consulting corporation, International Business Machines Corporation (IBM), has partnered with Memorial Sloan Kettering to explore the potential application of cognitive computing in examining images of skin lesions, in the hope ... Read more
    December 22, 2014December 22, 2014

    Airline Pilots Are Exposed To High Levels of UV-A Cockpit Radiation

    News
    A group of researchers from the University of California published a recent research letter in JAMA Dermatology whereby they state airline pilots could be exposed to the same levels of ... Read more
    December 19, 2014December 19, 2014

    Scientists Can Reprogram Skin Fibroblasts Into Melanocytes

    News
    A new study established a way to convert fibroblasts into functional melanocytes, the body’s pigment-producing cells. The study entitled “Direct conversion of mouse and human fibroblasts to functional melanocytes by ... Read more
    December 18, 2014December 18, 2014

    New Drugs To Treat Drug Resistant Melanoma Discovered by Researchers

    News
    In a recent study published in the journal Cancer Cell scientists at The Institute of Cancer Research, London, and the Cancer Research UK Manchester Institute, found a new family of drugs, ... Read more
    December 17, 2014December 17, 2014

    Study Finds Hair Shaft miRNA-221 Levels Can Be Used As Malignant Melanoma Biomarker

    News
    In a recent study titled “Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma”, published in The Journal of Dermatology, a team of researchers from Kumamoto University, Japan, ... Read more
    December 16, 2014December 16, 2014

    Study Evaluates Number of Nevi Biopsies in U.S. Children

    News
    In a recent research letter titled “Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013”, published in Jama Dermatology, a group of scientists led by ... Read more
    December 15, 2014December 15, 2014

    Study Finds Firefighters Have Increased Risk of Melanoma

    News
    A study led by Monash University researchers found that firefighters have an increased risk of developing melanoma and prostate cancer when compared to the general public. The analysis, appointed by ... Read more
    December 12, 2014December 12, 2014

    ImmunID To Begin PREDICT-ID Clinical Trial in Metastatic Melanoma Patients

    News
    A new study called PREDICT-ID Melanoma is going to assess the predictive value of immune profiles for response to the drug agent ipilimumab. The company that developed this agent, ImmunID, ... Read more
    December 11, 2014December 11, 2014

    Study Finds IL-17 and IL-22 Influence Non-Melanoma Skin Cancer Growth

    News
    In a recent study titled “Interleukin-17 and Interleukin-22 promote tumor progression in human non-melanoma skin cancer”, published ahead of print in the European Journal of Immunology, a group of researchers from ... Read more
    December 10, 2014December 10, 2014

    Amgen Begins Clinical Trial To Evaluate Talimogene Laherparepvec In Combination With KEYTRUDA For Advanced Melanoma

    News
    Amgen has announced it will initiate a clinical trial of talimogene laherparepvec, an investigational immunotherapy, in combination with Merck’s KEYTRUDA (pembrolizumab), in patients diagnosed with regionally or distantly metastatic melanoma. ... Read more
    December 9, 2014December 9, 2014

    Study Reviews The Use Of Melanoma Chemopreventive Agents

    News
    Even though there have been significant advances in drug discovery and molecular research to identify drug targets, the incidence and mortality rates associated with melanoma have been continuously rising. Commonly ... Read more
    December 8, 2014December 8, 2014

    Array Signed Agreement To Regain Worldwide Rights To Binimetinib

    News
    Array BioPharma Inc. has announced it reached a conclusive agreement with Novartis allowing it to recover complete worldwide rights to binimetinib, a MEK inhibitor currently being investigated in three Phase ... Read more
    December 5, 2014December 5, 2014

    Study Finds Proteomic Biomarkers in Metastatic Melanoma

    News
    In a recent study titled “Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation”, published in the PlosOne journal, a team of researchers led by Dr. Vito ... Read more
    December 4, 2014

    Study Finds Combined PV-10 And Immune Checkpoint Inhibitors Efficient In Melanoma Treatment

    News
    During the 29th annual meeting of the Society for Immunotherapy of Cancer, Dr. Shari Pilon-Thomas of the Moffitt Cancer Center, presented a study titled “Efficacy of Intralesional Injection with PV-10 ... Read more
    December 3, 2014December 3, 2014

    Study Finds TERT Mutations Could Predict Survival Outcome in Melanoma Patients

    News
    In a recent study titled “TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma”, published in the Journal of the National Cancer Institute (JNCI), a group of researchers ... Read more
    December 2, 2014

    Study Finds immunoSEQ Assay Could Be Used to Predict Pembrolizumab Response in Melanoma Patients

    News
    A recent study published in Nature, successfully demonstrated that Adaptive Biotechnologies’s immunoSEQ Assay could aid in the identification of patients suffering from metastatic melanoma who are more likely to respond ... Read more
    December 1, 2014December 1, 2014

    Study Investigates Potent Cancer Vaccine

    News
    Recent research developed by scientists at the Washington University School of Medicine in St. Louis, titled “Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens” and published in the prestigious Nature ... Read more
    November 28, 2014November 28, 2014

    Study Finds Mechanism Behind Melanoma Patients’ Response to Pembrolizumab

    News
    Recent work supported by the Stand Up To Cancer (SU2C) – Cancer Research Institute (CRI) – Immunology Translational Research Dream Team, was published ahead of print in the prestigious Nature ... Read more
    November 26, 2014November 26, 2014

    Study Finds Key Mutations in Melanoma Patients Responsive to Immunotherapy

    Melanoma, News
    Timothy Chan, MD, PhD, and oncology fellow Alexandra Snyder Charen, MD, at the Memorial Sloan Kettering Cancer Center, are working to advance the way melanoma patients are treated with immunotherapy. The ... Read more
    November 25, 2014November 25, 2014

    Study Evaluated CT Tumor Size and Density as Predictors of Response And Outcome in Advanced Melanoma

    News
    In a recent study titled “Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome”, published in the Journal ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.